A Phase III, Randomized, Double-Blind Placebo-Controlled, Multicenter Study To Evaluate the Efficacy and Safety of Baloxavir Marboxil in Combination With Standard-of-Care Neuraminidase Inhibitor in Hospitalized Participants With Severe Influenza
Phase of Trial: Phase III
Latest Information Update: 14 Feb 2019
At a glance
- Drugs Baloxavir-marboxil (Primary) ; Oseltamivir; Peramivir; Zanamivir
- Indications Influenza A virus infections; Influenza B virus infections
- Focus Registrational; Therapeutic Use
- Sponsors Roche
- 18 Dec 2018 New source identified and integrated(European Clinical Trials Database record: EudraCT2018-001416-30)
- 28 Nov 2018 Status changed from not yet recruiting to recruiting.
- 25 Oct 2018 Planned initiation date changed from 17 Oct 2018 to 30 Nov 2018.